Clinical Trial Update: Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT [Phase 2]

View source ↗

Summary

Phase 2 trial comparing cyclophosphamide to anti-thymocyte globulin for GVHD prophylaxis after reduced-intensity conditioning allogeneic stem cell transplant ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• anti-thymocyte globulin (antithymocyte globulin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Graft vs Host Disease | Phase 2 | Status: COMPLETED